FindTrial
Sign In

A prospective randomized control trial to compare high and low dose postoperative oestrogen therapy in the prevention of adhesion after hysteroscopic resection of intrauterine adhesions.

A prospective randomized control trial to compare high and low dose postoperative oestrogen therapy in the prevention of adhesion after hysteroscopic resection of intrauterine adhesions.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007295
Enrollment
Unknown
Registered
2015-10-09
Start date
2015-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine Adhesion

Interventions

low doses:oestrogen 2mg/d
high doses:oestrogen 6mg/d

Sponsors

Fuxing Hospital,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 48 Years

Inclusion criteria

Inclusion criteria: 1. Bearing-age women whose preoperation AFS score is 5-12; 2. Preoperative examination results are normal (sex hormone, hepatorenal function, thytoid function and blood glucose level); 3. Patients volunteered for this study.

Exclusion criteria

Exclusion criteria: 1. Patients took the hormone in the past month; 2. Patients has other diseases such as leiomyoma, polyps and the like; 3. Patients have the contraindications of the drug.

Design outcomes

Primary

MeasureTime frame
Postoperative uterine cavity recovery status;—

Secondary

MeasureTime frame
menstrual capacity;—

Countries

China

Contacts

Public ContactLiu Yu Huan
liuyh3844@sina.com+86 13801133844

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026